South Plains Financial, Inc. Announces Stock Repurchase Program
LUBBOCK, Texas, Feb. 26, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), today announced […]
Snap One Holdings Corp. to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024 at 4:30 p.m. ET
CHARLOTTE, N.C. , Feb. 26, 2024 (GLOBE NEWSWIRE) — Snap One Holdings Corp. (Nasdaq: SNPO) (“Snap One” or the “Company”), […]
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving […]
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study […]
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced […]
Jimmy Lee Appointed As Chairman Emeritus Of Mercer International Inc.
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) — Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC) announced that Jimmy […]
Zoom Video Communications Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Fourth quarter total revenue of $1,146.5 million, up 2.6% year over year as reported and 2.7% in constant currency; full […]
Phillips Edison & Company to Present at Citi’s 2024 Global Property CEO Conference
CINCINNATI, Feb. 26, 2024 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of […]
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]
